| http://www.w3.org/ns/prov#value | - On Thursday, the Israeli company announced an asset transfer agreement with the Danish company NeuroSearch, covering all the rights to Huntexil, which is being developed to alleviate hand-movement, balance and gait impairment, without the side effects, such as sedation and depression, common to other drugs.
|
